Bio logo
Cellular Growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022

Advanced Therapies Integrates 2022

Leonardo Royal Hotel London Tower Bridge, 20 October 2022

ADVANCED THERAPIES INTEGRATES 2022 DRAFT AGENDA

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

PLEASE NOTE The agenda and timings have not been finalised so maybe subject to change.

CELLULAR GROWTH

How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.

TECH TO TRANSLATE

Discover the scientific and technological innovations to support your ATMP getting to market.

MAKING IT

Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.

Registration and Networking

Registration and Networking

Welcome & Opening Remarks

Welcome & Opening Remarks

MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

Fireside Chat

An interview with: MARTIN MURPHY | Chief Executive Officer | Syncona Investment Management Limited
Interviewed by: MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

Fireside Chat

Session 1

Viable cells to viable sells

How do you develop an investible opportunity that is commercially viable?

On Target

Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.

Innovate to Elevate

Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.

Session 2

Pitch perfect: advancing therapies

How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.

Prepare for patients

What should you consider when getting an advanced therapy ready for First in Human trials? Does it have the 5Rs: right target, right tissue, right safety, right patient and right commercial potential?

Matchmaking

How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.

Session 3

VC judges: what is the X factor?

What are VC Investors looking for at different stages of the life cycle?  How is the current economic environment impacting Venture Capital?

Advancing into the clinic

What do you need to consider to progress advanced therapies through the clinical phase of development?

ATMP: house blend

Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.

Session 4

Healthy Economics for thriving ATMPs

How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?

License to thrill: ATMPs

How do you get a licence to market your ATMP? What to consider when thinking about post-marketing commitments and surveillance.

Oh Industry 4.0

How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.

Closing Remarks

Closing Remarks

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Cellular Growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022

Bio logo
Cellular Growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022

Advanced Therapies Integrates 2022

Leonardo Royal Hotel London Tower Bridge, 20 October 2022

ADVANCED THERAPIES INTEGRATES 2022 DRAFT AGENDA

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

PLEASE NOTE The agenda and timings have not been finalised so maybe subject to change.

Registration and Networking

Welcome & Opening Remarks

MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

An interview with: MARTIN MURPHY | Chief Executive Officer | Syncona Investment Management Limited
Interviewed by: MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

CELLULAR GROWTH

How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.

Viable cells to viable sells

How do you develop an investible opportunity that is commercially viable?

Pitch perfect: advancing therapies

How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.

VC judges: what is the X factor?

What are VC Investors looking for at different stages of the life cycle?  How is the current economic environment impacting Venture Capital?

Healthy Economics for thriving ATMPs

How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?

TECH TO TRANSLATE

Discover the scientific and technological innovations to support your ATMP getting to market.

On Target

Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.

Prepare for patients

What should you consider when getting an advanced therapy ready for First in Human trials? Does it have the 5Rs: right target, right tissue, right safety, right patient and right commercial potential?

Advancing into the clinic

What do you need to consider to progress advanced therapies through the clinical phase of development?

License to thrill: ATMPs

How do you get a licence to market your ATMP? What to consider when thinking about post-marketing commitments and surveillance.

MAKING IT

Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.

Innovate to Elevate

Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.

Matchmaking

How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.

ATMP: house blend

Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.

Oh Industry 4.0

How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Cellular Growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022